Get in touch

Oral Solid Dosage Manufacturing in India: A Complete Guide for Global Pharma Companies

Introduction

Tablets and capsules remain fundamental dosage forms across the global pharmaceutical industry. Their widespread use, manufacturing scalability, dosing convenience, product stability and suitability across numerous therapeutic areas make oral solid dosage forms an important part of pharmaceutical development and commercial manufacturing.

However, producing a tablet or capsule consistently at commercial scale involves far more than compressing a formulation into a finished dosage form.

Successful oral solid dosage form manufacturing requires expertise across formulation development, raw material handling, blending, granulation, drying, compression or encapsulation, coating, analytical testing, process validation and commercial-scale production.

These requirements can become even more specialized when manufacturers handle oncology or high-potency products.

India has developed a broad pharmaceutical development and manufacturing ecosystem supporting companies across domestic and international markets. For global pharmaceutical companies evaluating an oral solid dosage manufacturer in India, the focus should therefore extend beyond production capacity to scientific expertise, quality systems, technology transfer and long-term scalability.

This guide explains the major stages of oral solid dosage manufacturing and the capabilities pharmaceutical companies should evaluate when selecting a CDMO partner.

What Are Oral Solid Dosage Forms?

Oral solid dosage forms, commonly referred to as OSDs, are pharmaceutical products designed to deliver medicines through oral administration in a solid form.

The two most widely recognized categories are:

Within these categories, pharmaceutical companies can develop different formulations based on the therapeutic and product requirements.

Although the final dosage form may appear relatively simple, its performance depends on multiple formulation and manufacturing variables.

The active pharmaceutical ingredient needs to be combined with suitable excipients and processed under carefully developed conditions to produce the intended finished product.

This makes pharmaceutical formulation development a critical foundation for reliable OSD manufacturing.

Why Oral Solid Dosage Manufacturing Requires Technical Expertise

A commercially manufactured tablet or capsule must consistently meet its established product specifications.

Achieving this requires control over several interconnected factors.

These can include:

A change in one area can influence another.

For example, powder flow characteristics can affect manufacturing operations, while compression parameters can influence the physical properties of a tablet.

OSD manufacturing therefore requires both formulation knowledge and process understanding.

The Oral Solid Dosage Manufacturing Process

The exact manufacturing pathway depends on the product and formulation. However, commercial OSD production generally involves a structured sequence of pharmaceutical operations.

1. Raw Material Dispensing

Manufacturing begins with accurately dispensing the active pharmaceutical ingredient and required excipients according to the approved formulation.

Material identity, quantity and handling procedures are controlled through established manufacturing and quality processes.

For high-potency or oncology products, material handling may require additional containment measures.

2. Blending

The API and excipients need to be distributed appropriately throughout the formulation.

Blending therefore plays an important role in achieving product consistency.

Factors such as mixing time, equipment characteristics and material properties can influence the blending process.

3. Granulation

Some tablet formulations require granulation to improve material properties before compression.

Depending on the formulation and manufacturing approach, granulation can help improve areas such as:

The granulation process needs to be developed and controlled according to the characteristics of the formulation.

4. Drying

Where a manufacturing process includes wet granulation, the resulting material may require controlled drying.

Drying conditions can influence the properties of the granules and subsequent manufacturing performance.

Process parameters therefore need to be understood and controlled during development and scale-up.

5. Milling and Sizing

Granules may undergo milling or sizing to achieve suitable physical characteristics for subsequent manufacturing operations.

This stage helps prepare the material for blending, compression or encapsulation.

6. Tablet Compression

For tablets, the prepared formulation is compressed into individual dosage units using tablet compression equipment.

Manufacturing teams monitor appropriate process parameters to support consistent production.

The compression stage needs to be aligned with the formulation’s characteristics and established manufacturing process.

7. Capsule Filling

For capsule products, the prepared formulation is filled into suitable capsule shells using encapsulation equipment.

As with tablets, process controls are important to support consistency throughout commercial manufacturing.

8. Tablet Coating

Some tablet products require coating for functional or product-specific reasons.

Coating operations involve carefully controlled processing conditions and need to be integrated with the overall manufacturing strategy.

Formulation Development Comes Before Manufacturing

Commercial OSD manufacturing begins with a well-understood formulation.

During pharmaceutical R&D, scientists study how the active ingredient interacts with excipients and how the proposed formulation performs under different processing conditions.

Formulation development may evaluate:

The objective is to establish a formulation capable of progressing toward scalable manufacturing.

For this reason, pharmaceutical companies can benefit from working with a CDMO where formulation scientists and manufacturing teams are closely connected.

Analytical Development for Tablets and Capsules

Analytical methods provide important information about pharmaceutical product quality throughout development and manufacturing.

For oral solid dosage products, analytical activities can support the evaluation of product-specific characteristics such as:

Analytical methods developed during R&D also need to transition appropriately as the product moves toward commercial manufacturing.

An integrated pharmaceutical R&D services in India model can connect formulation development, analytical activities and manufacturing within the same development pathway.

Scaling an OSD Product from R&D to Commercial Manufacturing

A laboratory-scale formulation needs to be translated into a manufacturing process capable of operating at larger batch sizes.

This is known as pharmaceutical scale-up.

Moving from development equipment to commercial manufacturing equipment can introduce changes in:

These variables need to be evaluated scientifically.

A successful scale-up program therefore focuses on maintaining product and process understanding while increasing production scale.

Technology Transfer in Oral Solid Dosage Manufacturing

Technology transfer services in India play an important role when a pharmaceutical product moves from development into a manufacturing facility.

The transfer can involve:

Technology transfer should give the manufacturing team a clear understanding of both the process and the scientific knowledge developed during R&D.

When development and commercial manufacturing exist within the same CDMO, communication between teams can help maintain continuity throughout this transition.

Oral Solid Dosage Manufacturing for Oncology Products

OSD manufacturing takes on additional considerations when the product contains a high-potency or cytotoxic compound.

Many oncology medicines are administered as oral tablets or capsules. Manufacturing these products can therefore require expertise in both OSD processes and high-potency handling.

An experienced oncology pharmaceutical manufacturer needs to consider appropriate controls throughout operations such as:

Dispensing → Processing → Blending → Compression/Encapsulation → Cleaning → Material & Waste Handling

The manufacturing environment and processes should be appropriate for the products being handled.

This is where oncology specialization becomes particularly relevant.

High-Potency Oral Solid Dosage Manufacturing

High-potency pharmaceutical manufacturing requires an integrated approach to containment and process control.

For oral solid dosage forms, powders can move through several manufacturing stages before becoming finished tablets or capsules.

Appropriate handling strategies therefore need to extend across the production workflow.

The manufacturing partner should understand how product characteristics affect:

This makes high-potency OSD manufacturing a specialized capability rather than simply an extension of conventional tablet manufacturing.

Quality Systems in OSD Manufacturing

Reliable commercial manufacturing depends on established pharmaceutical quality systems.

Quality oversight can extend across areas such as:

Quality systems help ensure that manufacturing activities are performed according to established procedures and product requirements.

For global pharmaceutical companies, these systems are an important part of evaluating a potential pharmaceutical manufacturing company.

Process Validation and Commercial Readiness

Once the manufacturing process has been developed and transferred, appropriate validation activities support the transition toward routine commercial manufacturing.

Validation helps demonstrate that the established manufacturing process can operate consistently within defined conditions.

It brings together:

This stage connects development and technology transfer with routine commercial production.

Why India Is a Major Pharmaceutical Manufacturing Destination

India has built a large pharmaceutical ecosystem encompassing research, formulation development, analytical science, manufacturing and international supply.

For pharmaceutical companies seeking pharmaceutical contract manufacturing in India, this ecosystem provides access to experienced scientific and manufacturing professionals across a wide range of dosage forms and therapeutic areas.

India’s pharmaceutical capabilities extend across:

For global companies, the most suitable partner will ultimately depend on the technical and commercial requirements of the individual product.

Contract Manufacturer vs Integrated CDMO

A conventional contract manufacturer may primarily focus on producing an established pharmaceutical formulation.

A CDMO can provide a broader development pathway.

An integrated model can include:

R&D → Formulation Development → Analytical Development → Process Development → Technology Transfer → Scale-Up → Commercial Manufacturing

This can be particularly valuable for products that are still progressing through development.

Rather than transferring knowledge repeatedly between independent organizations, pharmaceutical companies can maintain a connected development and manufacturing pathway.

How to Choose an Oral Solid Dosage Manufacturer in India

Global pharmaceutical companies should evaluate several areas when selecting a manufacturing partner.

Formulation Development Expertise

Can the organization support products that require development or optimization?

Manufacturing Infrastructure

Does the facility have equipment suitable for the intended dosage forms and commercial requirements?

Technology Transfer

Can the partner effectively transition products from R&D to manufacturing?

Analytical Capabilities

Are appropriate analytical and stability capabilities available?

Scale-Up Experience

Can the manufacturer support increasing batch sizes as the product progresses?

High-Potency Capabilities

For oncology or potent products, does the manufacturer have appropriate specialization?

Quality Systems

Does the organization operate within established pharmaceutical quality systems?

Commercial Manufacturing

Can the partner support routine commercial production after development?

These factors help distinguish a long-term CDMO partner from a manufacturing provider focused only on individual production activities.

Teyro’s Oral Solid Dosage Manufacturing Capabilities

Teyro’s manufacturing platform includes oral solid dosage capabilities alongside its specialization in oncology, high-potency products and sterile injectables.

Its broader pharmaceutical capabilities include:

Teyro’s manufacturing infrastructure supports commercial production of oral solid dosage forms, including tablets and capsules.

The company’s integrated model allows pharmaceutical development, technology transfer and manufacturing to remain connected as products progress through their lifecycle.

The Value of Therapeutic and Manufacturing Specialization

Not every tablet or capsule requires the same manufacturing environment.

A conventional oral solid product and a high-potency oncology tablet can involve very different manufacturing considerations.

For pharmaceutical companies developing specialty medicines, the ideal manufacturing partner therefore needs expertise in both the dosage form and therapeutic/manufacturing complexity of the product.

Teyro’s focus on oncology and high-potency products provides this additional specialization alongside its OSD manufacturing platform.

Building a Scalable OSD Manufacturing Partnership

The requirements of a pharmaceutical product can change significantly over its lifecycle.

Early in development, the priority may be formulation and analytical work.

Later, the focus can shift toward:

Selecting a partner capable of supporting these different stages can provide continuity as the product progresses.

For global pharmaceutical companies, this makes integrated CDMO capabilities increasingly relevant when establishing long-term manufacturing partnerships.

Conclusion

Oral solid dosage form manufacturing combines pharmaceutical science, process engineering, analytical expertise, quality management and commercial manufacturing.

Although tablets and capsules are well-established dosage forms, producing them consistently at commercial scale requires a carefully developed and controlled manufacturing process.

The requirements become even more specialized for oncology and high-potency products, where manufacturing expertise needs to be combined with appropriate handling and containment strategies.

For pharmaceutical companies evaluating an oral solid dosage manufacturer in India, capabilities across R&D, technology transfer, scale-up, quality and commercial manufacturing should therefore be considered together.

Teyro brings these capabilities into an integrated specialty pharmaceutical CDMO platform, supporting oral solid dosage products alongside oncology, high-potency and sterile manufacturing programs.

Call to Action

Looking for an oral solid dosage manufacturing and CDMO partner in India?

Teyro provides integrated support across pharmaceutical R&D, formulation development, technology transfer, tablet and capsule manufacturing, oncology and high-potency manufacturing, sterile injectables and commercial production.

Connect with Teyro to discuss your oral solid dosage development and manufacturing requirements.